IDO1 and cancer: Currently, several IDO inhibitors (Indoximod, Epacadostat, Navoximod, Linrodostat Mesilate, PF-06840003, KHK2455, etc.)form part of clinical trials to evaluate their efficacy in enhancing immunotherapy in various cancer types [137].